ICGEB Cape Town seminar with Prof. Jennifer A. Thomson (OWSD) | 10 February 2023
The International Centre for Genetic Engineering and Biotechnology (ICGEB) is organising a series of initiatives for the UN Day of Women and Girls in Science. On 10 February 2023, ICGEB Cape Town group leader Lara Donaldson will be hosting a seminar by Prof. Jennifer A. Thomson, President of OWSD (Organization for Women in Science for the Developing World) from South Africa. OWSD is a programme unit of UNESCO aiming to unite eminent women scientists from the developing and developed worlds with the objective of strengthening their role in the development process and promoting their representation in scientific and technological leadership. OWSD provides research training, career development and networking opportunities for women scientists throughout the developing world at different stages in their careers.
The seminar will start at 11:00 (South Africa time) and can be accessed through Zoom after registration.
Register for the seminar by sending an email to capetown@icgeb.org
More information about the activities https://www.icgeb.org/our-initiatives-for-the-un-day-of-women-and-girls-in-science/
Global Health EDCTP3 2023 Info Day
On 23rd March 2023 Global Health EDCTP3 will host its first 2023 Info day. The event will provide potential applicants with specific information on the Global Health EDCTP3 calls for proposals and funding opportunities under Work Programme 2023, as well as information on eligibility criteria and other relevant administrative matters.
The event will also give further guidance to, in particular, research stakeholders based in Africa regarding participation in Global Health EDCTP3 projects and potential membership to the EDCTP Association.
Global Health EDCTP3 invites African and European researchers and innovators as well as citizens and all interested stakeholders to take part in the Info Day.
During the event, questions from the audience will be answered via Slido. Further information will be circulated shortly and posted on the interim Global Health EDCTP3 website.
A second Info day is planned for 12 April 2022.
When: Thursday 23 March 2023, 13:00 – 15:00 Central European Time (CET) / 14:00 – 16:00 South Africa Standard Time (SAST)
Where: Online
Languages: English
Webinar: EDCTP COVID-19 Emergency Funding Mechanism - Collaborative clinical research studies in Sub-Saharan Africa, 18-19 March 2021
EDCTP activated its Emergency Funding Mechanism in April 2020 to support collaborative clinical research studies in sub-Saharan Africa to manage and/or prevent the spread of the current COVID-19 outbreak. Twenty-six projects have been supported in 22 countries across sub-Saharan Africa. One year on from the declaration of COVID-19 as a pandemic, many research questions have been answered, many others are still under investigation and new questions are emerging.
Speakers & Participants
Speakers will primarily include representatives of the EDCTP-funded COVID-19 Emergency Projects. Selected speakers will share preliminary findings (where available) and/or lessons learnt so far. The meeting will be open to researchers and all other interested stakeholders.
Agenda
The programme includes presentations and panel discussions on the following topics:
- Surveillance and response
- Focus on special populations (pediatric, pregnant women)
- COVID-19 and other major infectious diseases in sub-Saharan Africa (HIV, TB, Malaria)
- New emerging research questions and knowledge gaps specific to sub-Saharan Africa
When and How to join?
The meeting will be held in 2 separate afternoons via Zoom on 18-19 March 2021, each day from 1 to 5PM Central European Time (CET). Registration is required (one link for both days).
Register in advance for this webinar: https://zoom.us/webinar/register/WN_cHhn2t0SQvuNJYemkJesBg
Call for experts: Gavi Vaccine Investment Strategy (VIS) Steering Committee open for applications (deadline: 28 September 2022)
Gavi has launched a call for expressions of interest to identify members for the Vaccine Investment Strategy (VIS) Steering Committee. The Steering Committee will be convened to provide expert advice, strategic guidance, and oversight to the next VIS. This is Gavi’s evidence-driven process for identifying new and under-used vaccines of the highest importance to Gavi-supported countries and inform on options for future investments. The VIS takes place every 5 years. The next VIS will kick off later this year, with multiple decision steps culminating in final investment case decisions taken by the Gavi Board in June 2024.
The deadline to receive expressions of interest is 28 September 2022.
More information and applying: https://www.gavi.org/news/media-room/gavi-vaccine-investment-strategy-steering-committee-now-open-applications